$GRTX
Galera Therapeutics, Inc.

2019 Q4 Form 10-Q Financial Statement

#000156459019045585 Filed on December 10, 2019

View on sec.gov

Income Statement

Concept 2019 Q4 2019 Q3 2018 Q3
Revenue $0.00 $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.890M $1.820M $1.250M
YoY Change 65.14% 45.6%
% of Gross Profit
Research & Development $13.28M $11.04M $4.160M
YoY Change 86.78% 165.38%
% of Gross Profit
Depreciation & Amortization $80.00K $80.00K $30.00K
YoY Change 100.0% 166.67%
% of Gross Profit
Operating Expenses $16.17M $11.04M $5.410M
YoY Change 82.51% 104.07%
Operating Profit -$12.86M -$5.407M
YoY Change 137.77%
Interest Expense -$510.0K $918.0K $110.0K
YoY Change -342.86% 734.55%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$16.68M -$13.35M -$5.301M
YoY Change 92.83% 151.86%
Income Tax -$10.00K $0.00 -$52.00K
% Of Pretax Income
Net Earnings -$16.67M -$13.35M -$5.249M
YoY Change 94.74% 154.35%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$671.6K -$538.1K -$215.5K
COMMON SHARES
Basic Shares Outstanding 24.81M
Diluted Shares Outstanding

Balance Sheet

Concept 2019 Q4 2019 Q3 2018 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $112.3M $67.90M
YoY Change 37.79%
Cash & Equivalents $18.36M $15.72M $53.02M
Short-Term Investments $93.90M $52.20M
Other Short-Term Assets $5.300M $4.200M
YoY Change 253.33%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $117.6M $72.14M
YoY Change 40.21%
LONG-TERM ASSETS
Property, Plant & Equipment $934.0K $970.0K
YoY Change 64.44%
Goodwill $881.0K $881.0K
YoY Change 0.0%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $918.0K $528.0K
YoY Change 84.71%
Total Long-Term Assets $5.806M $7.616M
YoY Change 38.11%
TOTAL ASSETS
Total Short-Term Assets $117.6M $72.14M
Total Long-Term Assets $5.806M $7.616M
Total Assets $123.4M $79.76M
YoY Change 40.11%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $3.945M $5.218M
YoY Change 2.02%
Accrued Expenses $5.452M $3.574M
YoY Change 111.56%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $9.694M $9.083M
YoY Change 50.43%
LONG-TERM LIABILITIES
Long-Term Debt $43.30M $42.30M
YoY Change 114.36%
Other Long-Term Liabilities $500.0K $600.0K
YoY Change
Total Long-Term Liabilities $43.80M $42.90M
YoY Change 116.83%
TOTAL LIABILITIES
Total Short-Term Liabilities $9.694M $9.083M
Total Long-Term Liabilities $43.80M $42.90M
Total Liabilities $53.77M $52.30M
YoY Change 99.33%
SHAREHOLDERS EQUITY
Retained Earnings -$161.4M -$144.7M
YoY Change 53.93%
Common Stock $230.9M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $69.61M -$144.6M -$94.44M
YoY Change
Total Liabilities & Shareholders Equity $123.4M $79.76M
YoY Change 40.11%

Cashflow Statement

Concept 2019 Q4 2019 Q3 2018 Q3
OPERATING ACTIVITIES
Net Income -$16.67M -$13.35M -$5.249M
YoY Change 94.74% 154.35%
Depreciation, Depletion And Amortization $80.00K $80.00K $30.00K
YoY Change 100.0% 166.67%
Cash From Operating Activities -$15.27M -$12.91M -$5.060M
YoY Change 130.66% 155.14%
INVESTING ACTIVITIES
Capital Expenditures -$60.00K -$60.00K -$20.00K
YoY Change -80.0% 200.0%
Acquisitions
YoY Change
Other Investing Activities -$41.72M $12.83M -$15.42M
YoY Change -18.64% -183.2%
Cash From Investing Activities -$41.80M $12.77M -$15.44M
YoY Change -18.98% -182.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 59.70M -340.0K 69.85M
YoY Change 198.65% -100.49%
NET CHANGE
Cash From Operating Activities -15.27M -12.91M -5.060M
Cash From Investing Activities -41.80M 12.77M -15.44M
Cash From Financing Activities 59.70M -340.0K 69.85M
Net Change In Cash 2.630M -480.0K 49.35M
YoY Change -106.88% -100.97%
FREE CASH FLOW
Cash From Operating Activities -$15.27M -$12.91M -$5.060M
Capital Expenditures -$60.00K -$60.00K -$20.00K
Free Cash Flow -$15.21M -$12.85M -$5.040M
YoY Change 140.66% 154.96%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
true
dei Entity Small Business
EntitySmallBusiness
true
dei Amendment Flag
AmendmentFlag
false
CY2019Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
4197000
CY2019Q3 us-gaap Assets Current
AssetsCurrent
72142000
CY2019Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15719000
CY2019Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
970000
CY2019Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
528000
CY2019Q3 us-gaap Assets
Assets
79758000
CY2019Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
5218000
CY2019Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3574000
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2019Q3 us-gaap Long Term Debt And Capital Lease Obligations Current
LongTermDebtAndCapitalLeaseObligationsCurrent
291000
CY2019Q3 us-gaap Liabilities Current
LiabilitiesCurrent
9083000
dei Entity Central Index Key
EntityCentralIndexKey
0001563577
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24807789
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
14811000
CY2019Q3 us-gaap Preferred Stock Value
PreferredStockValue
CY2018Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q3 us-gaap Short Term Investments
ShortTermInvestments
52226000
CY2018Q4 us-gaap Short Term Investments
ShortTermInvestments
66706000
dei Entity File Number
EntityFileNumber
001-39114
dei Entity Address Address Line1
EntityAddressAddressLine1
2 W Liberty Blvd #100
dei Entity Address City Or Town
EntityAddressCityOrTown
Malvern
dei Security12b Title
Security12bTitle
Common Stock, $0.001 par value per share
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19355
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei City Area Code
CityAreaCode
610
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-1454898
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Type
DocumentType
10-Q
dei Entity Registrant Name
EntityRegistrantName
Galera Therapeutics, Inc.
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
dei Document Period End Date
DocumentPeriodEndDate
2019-09-30
dei Trading Symbol
TradingSymbol
GRTX
dei Entity Address State Or Province
EntityAddressStateOrProvince
PA
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Transition Report
DocumentTransitionReport
false
dei Local Phone Number
LocalPhoneNumber
725-1500
dei Entity Shell Company
EntityShellCompany
false
CY2018Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-11000
CY2019Q3 us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-3000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-104823000
CY2019Q3 us-gaap Stockholders Equity
StockholdersEquity
-144620000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-104820000
CY2019Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
79758000
CY2019Q3 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
96385795
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
88056000
CY2019Q3 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2018Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
0.001
CY2019Q3 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
96385795
CY2018Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
96385795
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
497000
CY2018Q4 us-gaap Assets
Assets
88056000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3867000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2577000
CY2018Q4 us-gaap Deferred Rent Credit Noncurrent
DeferredRentCreditNoncurrent
12000
CY2019Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
55000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
3000
CY2019Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-144675000
CY2018Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
870000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1465000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
83852000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
568000
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2258000
CY2018Q4 us-gaap Goodwill
Goodwill
881000
CY2019Q3 grtx Deferred Offering Costs Noncurrent
DeferredOfferingCostsNoncurrent
2103000
CY2019Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
876000
CY2018Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
96385795
CY2019Q3 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
96385795
CY2018Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
96385795
CY2019Q3 us-gaap Temporary Equity Liquidation Preference
TemporaryEquityLiquidationPreference
174746000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
29057000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11551000
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1816000
CY2018Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1245000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5466000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3846000
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12856000
CY2018Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-5407000
us-gaap Operating Income Loss
OperatingIncomeLoss
-34523000
us-gaap Operating Income Loss
OperatingIncomeLoss
-15397000
CY2019Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
426000
CY2018Q3 us-gaap Investment Income Interest
InvestmentIncomeInterest
117000
us-gaap Investment Income Interest
InvestmentIncomeInterest
1397000
us-gaap Investment Income Interest
InvestmentIncomeInterest
170000
CY2019Q3 us-gaap Interest Expense
InterestExpense
918000
us-gaap Interest Expense
InterestExpense
2094000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-38000
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
-27000
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13351000
CY2018Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-5301000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-35258000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-15254000
CY2018Q4 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
298000
CY2018Q4 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
20220000
CY2019Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
604000
CY2019Q3 us-gaap Deferred Tax Liabilities Derivatives
DeferredTaxLiabilitiesDerivatives
298000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6444000
CY2019Q3 us-gaap Royalty Guarantees Commitments Amount
RoyaltyGuaranteesCommitmentsAmount
42313000
CY2019Q3 us-gaap Goodwill
Goodwill
881000
CY2019Q3 us-gaap Liabilities
Liabilities
52298000
CY2019Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2258000
CY2018Q4 us-gaap Liabilities
Liabilities
26974000
CY2018Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-52000
CY2019Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-13377000
CY2018Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-5249000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-35206000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-15110000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
-76105000
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
208000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
-12006000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
-129656000
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
520000
CY2019Q3 grtx Increase Decrease In Temporary Equity Redemption Value
IncreaseDecreaseInTemporaryEquityRedemptionValue
-2107000
us-gaap Profit Loss
ProfitLoss
-35258000
us-gaap Profit Loss
ProfitLoss
-15113000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-141000
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
-13351000
CY2018Q3 us-gaap Net Income Loss
NetIncomeLoss
-5249000
us-gaap Net Income Loss
NetIncomeLoss
-35258000
us-gaap Net Income Loss
NetIncomeLoss
-15113000
CY2019Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
2108000
CY2018Q3 us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
1468000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
6178000
us-gaap Temporary Equity Accretion To Redemption Value Adjustment
TemporaryEquityAccretionToRedemptionValueAdjustment
3879000
CY2019Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-15459000
us-gaap Depreciation
Depreciation
188000
us-gaap Depreciation
Depreciation
86000
us-gaap Paid In Kind Interest
PaidInKindInterest
2094000
us-gaap Share Based Compensation
ShareBasedCompensation
1584000
us-gaap Share Based Compensation
ShareBasedCompensation
654000
grtx Reserve For Tax Incentive Receivable
ReserveForTaxIncentiveReceivable
241000
CY2018Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6717000
grtx Increase Decrease In Deferred Tax Liability
IncreaseDecreaseInDeferredTaxLiability
-141000
grtx Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
7000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-41436000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-18992000
CY2019Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-51.43
grtx Increase Decrease In Deferred Rent
IncreaseDecreaseInDeferredRent
-1000
CY2018Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-22.35
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-137.85
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-63.18
CY2019Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
300597
grtx Increase Decrease In Tax Incentive Receivable
IncreaseDecreaseInTaxIncentiveReceivable
-629000
CY2018Q1 grtx Increase Decrease In Temporary Equity Redemption Value
IncreaseDecreaseInTemporaryEquityRedemptionValue
-1205000
CY2018Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
-5533000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
-82632000
CY2018Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
226000
CY2018Q2 grtx Increase Decrease In Temporary Equity Redemption Value
IncreaseDecreaseInTemporaryEquityRedemptionValue
-1206000
CY2018Q2 us-gaap Net Income Loss
NetIncomeLoss
-4331000
CY2018Q2 us-gaap Stockholders Equity
StockholdersEquity
-87943000
CY2018Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
220000
CY2018Q3 grtx Increase Decrease In Temporary Equity Redemption Value
IncreaseDecreaseInTemporaryEquityRedemptionValue
-1468000
CY2018Q3 us-gaap Stockholders Equity
StockholdersEquity
-94440000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
499000
CY2018Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
300597
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
300597
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
300597
CY2019Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-26000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
52000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
3000
grtx Payment Of Deferred Offering Costs
PaymentOfDeferredOfferingCosts
1672000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
18328000
CY2019Q1 grtx Increase Decrease In Temporary Equity Redemption Value
IncreaseDecreaseInTemporaryEquityRedemptionValue
-2011000
CY2019Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
10000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
-9901000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
-116223000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
565000
CY2019Q2 grtx Increase Decrease In Temporary Equity Redemption Value
IncreaseDecreaseInTemporaryEquityRedemptionValue
-2060000
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
68000
grtx Increase Decrease In Tax Incentive Receivable
IncreaseDecreaseInTaxIncentiveReceivable
149000
us-gaap Proceeds From Issuance Of Redeemable Convertible Preferred Stock
ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
69850000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2732000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
168000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
31000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
255000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1131000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-308000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
762000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-153000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-31385000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-15548000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
63468000
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
16406000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
78000000
us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
9000000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
567000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
48000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13965000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-7454000
grtx Proceeds From Royalty Purchase Agreement
ProceedsFromRoyaltyPurchaseAgreement
20000000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69850000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
908000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
46848000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14811000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6169000
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15719000
CY2018Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
53017000
grtx Accretion Of Redeemable Convertible Preferred Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue
6178000
grtx Accretion Of Redeemable Convertible Preferred Stock To Redemption Value
AccretionOfRedeemableConvertiblePreferredStockToRedemptionValue
3879000
grtx Deferred Offering Costs Included In Accounts Payable And Accrued Expenses
DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses
431000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
24000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
268000
grtx Initial Recognition Of Operating Lease Right Of Use Asset And Operating Lease Liability
InitialRecognitionOfOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability
1084000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-style:italic;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;">Use of estimates </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:9.06%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of unaudited interim consolidated financial statements in conformity with U.S.&#160;GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the unaudited interim consolidated financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:9.06%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Estimates and assumptions are periodically reviewed and the effects of revisions are reflected in the unaudited interim consolidated financial statements in the period they are determined to be necessary. Significant areas that require management&#8217;s estimates include the fair value of common stock, share-based compensation assumptions, and accrued clinical trial expense. </p>
dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2012-11-19
us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
The Company effected a one-for-5.056564 reverse stock split of its common stock on October 25, 2019. The reverse stock split combined each approximately five shares of the Company’s issued and outstanding common stock into one share of common stock and correspondingly adjusted the conversion price of its redeemable convertible preferred stock
us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.197762749566702
grtx Proceeds From Royalty Purchase Agreement
ProceedsFromRoyaltyPurchaseAgreement
40000000
CY2019Q3 grtx Tax Incentive Receivable Reserve
TaxIncentiveReceivableReserve
600000
us-gaap Property Plant And Equipment Depreciation Methods
PropertyPlantAndEquipmentDepreciationMethods
Straight-line method
CY2019Q3 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
22160591
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21133118
CY2019Q3 us-gaap Fair Value Liabilities Measured On Recurring Basis Debt Instrument Valuation Techniques Change In Technique Quantification Of Effect
FairValueLiabilitiesMeasuredOnRecurringBasisDebtInstrumentValuationTechniquesChangeInTechniqueQuantificationOfEffect
0
us-gaap Fair Value Liabilities Measured On Recurring Basis Debt Instrument Valuation Techniques Change In Technique Quantification Of Effect
FairValueLiabilitiesMeasuredOnRecurringBasisDebtInstrumentValuationTechniquesChangeInTechniqueQuantificationOfEffect
0
CY2019Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1333000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
775000
CY2019Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
363000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
207000
CY2019Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
806000
CY2018Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
776000
CY2019Q3 grtx Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
2318000
CY2018Q4 grtx Accrued Research And Development Expense Current
AccruedResearchAndDevelopmentExpenseCurrent
1665000
CY2019Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
450000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
136000
us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
332000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
264000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
262000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
45000
CY2019Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
987000
CY2019Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
75000
CY2019Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
912000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
440000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
460000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
392000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
391000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
65000
CY2018Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1748000
CY2019Q3 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
172080000
CY2019Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
520000
CY2018Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
220000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1584000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
654000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2071616
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1146367
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
118894
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3099089
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1906827
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
3099089
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.17
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
7.45
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
5.36
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
4.00
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
2.42
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
4.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y1M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P7Y1M6D
CY2019Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
5600000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P3Y1M6D
CY2019Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
17400000
CY2019Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
13700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.61
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
3.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P7Y9M18D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.900
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.880
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0251
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0279
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2019Q3 us-gaap Share Price
SharePrice
7.45
CY2018Q3 us-gaap Share Price
SharePrice
4.38

Files In Submission

Name View Source Status
0001564590-19-045585-index-headers.html Edgar Link pending
0001564590-19-045585-index.html Edgar Link pending
0001564590-19-045585.txt Edgar Link pending
0001564590-19-045585-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
grtx-10q_20190930.htm Edgar Link pending
grtx-20190930.xml Edgar Link completed
grtx-20190930.xsd Edgar Link pending
grtx-20190930_cal.xml Edgar Link unprocessable
grtx-20190930_def.xml Edgar Link unprocessable
grtx-20190930_lab.xml Edgar Link unprocessable
grtx-20190930_pre.xml Edgar Link unprocessable
grtx-ex311_9.htm Edgar Link pending
grtx-ex312_8.htm Edgar Link pending
grtx-ex321_6.htm Edgar Link pending
grtx-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending